Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment

Radiotherapy and Oncology

Volumn 82, Issue 3, 2007, Pages 287-293

  Livi, Lorenzo ^a   Paiar, Fabiola ^a   Saieva, Calogero ^c   Scoccianti, Silvia ^a   Dicosmo, Dora ^a   Borghesi, Simona ^a   Agresti, Benedetta ^a   Nosi, Fabiano ^a   Orzalesi, Lorenzo ^b   Santini, Roberto ^a   Barca, Raffaella ^a   Biti, Giampaolo P ^a  

^a Department of Radiation Oncology ^*  (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

Author keywords

Breast cancer; Conserving surgery; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CONFIDENCE INTERVAL; DRUG USE; FOLLOW UP; HUMAN; ITALY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; TAMOXIFEN;

EID: 33847619723     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.11.009     Document Type: Article

References (26)

1. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-years follow-up a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
2. Fisher B., Anderson S., Briant J., et al. and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1642-1643
3. Vinh-Hung V., Burzykowski T., Van de Steene J., et al. Post-surgery in early breast cancer: survival analysis of register data. Radiother Oncol 64 (2002) 281-290
4. Markiewicz D.A., Schultz D.J., Haas J.A., et al. The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy. Int J Radiat Oncol Biol Phys 35 (1996) 661-668
5. Fowble B.L., Solin L.J., Schultz D.J., et al. Ten year results of conservative surgery and irradiation for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 21 (1991) 269-277
6. Beadle G.F., Silver B., Botnick L., et al. Cosmetic results following primary radiation therapy for early breast cancer. Cancer 54 (1984) 2911-2918
7. van Dongen J.A., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92 (2002) 1143-1150
8. Arriagada R., Le M.G., Rochard F., et al., for the Institut Gustave-Roussy Breast Cancer Group. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. J Clin Oncol 14 (1996) 1558-1564
9. Fourquet A., Campana F., Zafrani B., et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 17 (1989) 719-725
10. Haffty B.G., Goldberg N.B., Rose M., et al. Conservative surgery with radiation therapy in clinical stage I and II breast cancer: results of a 20-year experience. Arch Surg 124 (1989) 1266-1270
11. Obedian E., and Haffty B.G. Negative margin status improves local control in conservatively managed breast cancer patients. Cancer J Sci Am 6 (2000) 28-33
12. Kaplan E.L., and Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-458
13. Peto R., Pike M.C., and Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35 (1977) 1-39
14. Cox D.R. Regression models and life-tables. J R Stat Soc B 334 (1972) 187-202
15. van Oosterom A.T. Docetaxel (taxotere): an effective agent in the management of second-line breast cancer. Semin Oncol 22 (1995) 22-28
16. Holmes F.A., Walters R.S., Theriault R.L., et al. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83 (1991) 1797-1805
17. Nabholtz J.M., Senn H.J., Bezwoda W.R., et al. Prospective randomised trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracyclinecontaining chemotherapy. J Clin Oncol 17 (1999) 1413-1424
18. Chan S., Friedrichs K., Noel D., et al. Prospective randomised trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol 17 (1999) 2341-2354
19. Sledge G.W., Neuberg D., Bernardo P., et al. Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an Intergroup trial (E1193). J Clin Oncol 21 (2003) 588-592
20. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet 2000:355;1757-1770.
21. Fisher B., Bryant J., Dignam J.J., et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20 (2002) 4141-4149
22. Early Breast Cancer Trialists' Collaborative Group (EBCTCG)*. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005:365;1687-1717.
23. Horiguchi J., Koibuchi Y., Takei H., et al. Breast-conserving surgery following radiation therapy of 50 Gy in Stages I and II carcinoma of the breast: the experience at one institute in Japan. Oncol Rep 9 (2002) 1053-1057
24. Huston T.L., and Simmons R.M. Locally recurrent breast cancer after conservation therapy. Am J Surg 189 (2005) 229-235
25. Horst K.C., Smitt M.C., Goffinet D.R., et al. Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer 5 (2005) 425-438
26. Bartelink H., Horiot J.C., Poortmans P., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345 (2001) 1378-1387